U.S. Adds Jobs in June, But Trade War Could Slow Growth
*By Michael Teich*
Wall Street applauded a better-than-expected June jobs report, sending the Dow Industrials Index nearly 100 points higher Friday.
Despite those numbers, though, the U.S. economy is still grappling with growing trade tensions with China and Europe. The Trump administration's tariffs officially went into effect early Friday morning as the U.S. followed through on its threat to impose taxes on $34 billion of Chinese imports. China promptly responded with a similarly seized tariffs on U.S. goods, including pork, soybeans, and electric vehicles.
If trade wars accelerate, "the downside risks outweigh the upside risks," said Mark Hamrick, Senior Economic Analyst, Bankrate.com.
"The trade disputes are having impacts that are real in the economy right now."
The U.S. added 213,000 jobs in June, topping the forecast of 195,000. It was the 93rd consecutive month of job growth. The unemployment rate, however, rose to 4 percent as more people returned to the job market searching for work.
For the full segment, [click here.](https://cheddar.com/videos/u-s-job-growth-beats-expectations)
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
